Enveric Biosciences, Inc.
Novel small-molecule therapeutics targeting neuroplastogenic pathways for neuropsychiatric disorders
- Sector
- Biotech
- Headquarters
- CAMBRIDGE, MA
- Latest Form D
- $5M, May 2026
- Total capital
- $21.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $21.2M
- 8 Form D · last May 2026
- 6 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 11 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 7th filing$5M
- Private capital raisedForm D · SEC · 6th filing$1.5M
- Private capital raisedForm D · SEC · 5th filing$107K
- Private capital raisedForm D · SEC · 4th filing$8.6M
- Offering registeredForm D · SEC · 3rd filing$8.4M
- Offering registeredForm D · SEC · 2nd filing$8.2M
- Private capital raisedForm D · SEC · 1st filing$6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Founders and team
From SEC Form D filings- Avani KanubaddiExecutive Officer, DirectorNamed in SEC Form D filings
- Bevin O'NeilDirectorNamed in SEC Form D filings
- Bevin O'NielDirectorNamed in SEC Form D filings
- Bob DagherExecutive OfficerNamed in SEC Form D filings
- Carter WardExecutive OfficerNamed in SEC Form D filings
- David JohnsonExecutive Officer, DirectorNamed in SEC Form D filings
Show all 23 people
- Douglas LindDirectorNamed in SEC Form D filings
- Dr. Bob DagherExecutive OfficerNamed in SEC Form D filings
- Dr. Douglas LindDirectorNamed in SEC Form D filings
- Dr. Marcus SchabackerDirectorNamed in SEC Form D filings
- Frank PasqualoneDirectorNamed in SEC Form D filings
- George W. KeglerDirectorNamed in SEC Form D filings
- John Van BuitenExecutive OfficerNamed in SEC Form D filings
- Joseph E. TuckerExecutive Officer, DirectorNamed in SEC Form D filings
- Joseph Tucker, PhDExecutive Officer, DirectorNamed in SEC Form D filings
- Kevin M. CoveneyExecutive OfficerNamed in SEC Form D filings
- Marcus SchabackerDirectorNamed in SEC Form D filings
- Michael W. SchabackerDirectorNamed in SEC Form D filings
- Michael D. WebbDirectorNamed in SEC Form D filings
- Peter FacchiniExecutive OfficerNamed in SEC Form D filings
- Peter Facchini, PhDExecutive OfficerNamed in SEC Form D filings
- Sheila W. DeWittDirectorNamed in SEC Form D filings
- Sol MayerDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 11- PendingCompositions For Topical Treatment Of Radiation DermatitisUSPTOApplication 17869689
- PendingCompositions For Topical Treatment Of Radiation DermatitisUSPTOApplication 63321260
- PendingCompositions For Topical Treatment Of Radiation DermatitisUSPTOApplication 63321281
Show all 11 patent records
- Compositions For Topical Treatment Of Radiation DermatitisFeb 9, 2023 · Application 17869689Pending
- Compositions For Topical Treatment Of Radiation DermatitisApplication 63321260Pending
- Compositions For Topical Treatment Of Radiation DermatitisApplication 63321281Pending
- Cannabinoid Conjugate MoleculesApplication 63321360Pending
- Cannabinoid Conjugate MoleculesApplication 63321319Pending
- Cannabinoid Conjugate Molecules Containing A COX-2 InhibitorApplication 63321341Pending
- Cannabidiol Conjugate Molecules Containing A COX-2 InhibitorApplication 63312695Pending
- Compositions For Topical Treatment Of Radiation DermatitisApplication 63309194Pending
- Cannabidiol Conjugate MoleculesApplication 63305339Pending
- Compositions For Topical Treatment Of Radiation DermatitisApplication 63390933Pending
- Compositions For Topical Treatment Of Radiation DermatitisApplication 63223697Pending
Related companies, and why
- Mestag TherapeuticsSimilar federal contract value in Biotech · null in contracts
- VASCULONICS INCSimilar federal contract value in Biotech · null in contracts
- PredxBio, Inc.Similar federal contract value in Biotech · null in contracts
- Lydex Pharmaceuticals LLCSimilar federal contract value in Biotech · null in contracts
- MULTIMERIC BIOTHERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- NeuroKine Therapeutics, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .